International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 421-430 , May 2010

Treatment options for 2009 H1N1 influenza: evaluation of the published evidence

  • Matthew E. Falagas

      Affiliations

    • Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
    • Department of Medicine, Henry Dunant Hospital, Athens, Greece
    • Department of Medicine, Tufts University School of Medicine, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +30 694 61 10 000; fax: +30 210 68 39 605.
  • ,
  • Evridiki K. Vouloumanou

      Affiliations

    • Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
  • ,
  • Evagelia Baskouta

      Affiliations

    • Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
  • ,
  • Petros I. Rafailidis

      Affiliations

    • Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
    • Department of Medicine, Henry Dunant Hospital, Athens, Greece
  • ,
  • Kostantinos Polyzos

      Affiliations

    • Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Athens, Greece
  • ,
  • Jordi Rello

      Affiliations

    • Critical Care Department, Joan XXIII University Hospital, CIBERes Enfermedades Respiratorias, IISPV, Mallafre Guasch 4 (43007) Tarragona, Spain

References 

  1. Falagas ME, Kiriaze IJ. Reaction to the threat of influenza pandemic: the mass media and the public. Crit Care. 2006;10:408
  2. Peppas G, Theocharis G, Karveli EA, Falagas ME. An analysis of patient house calls in the area of Attica, Greece. BMC Health Serv Res. 2006;6:112
  3. World Health Organization. Pandemic (H1N1) 2009—update 73. Geneva, Switzerland; WHO; 2009. http://www.who.int/csr/don/2009_11_06/en/index.html [accessed 22 January 2010].
  4. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925–1933
  5. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–2615[Erratum in: N Engl J Med 2009;361:102]
  6. Hackett S, Hill L, Patel J, Ratnaraja N, Ifeyinwa A, Farooqi M, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet. 2009;374:605
  7. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–689
  8. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896–1902
  9. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis—North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009;58:969–72.
  10. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients—Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009;58:893–6.
  11. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–1879
  12. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302:1880–1887
  13. Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States, April–August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941–7.
  14. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148
  15. Raffo L. Influenza A(H1N1) epidemic in Argentina. Experience in a National General Hospital (Hospital Nacional Alejandro Posadas). Medicina (B Aires). 2009;69:393–423[in Spanish]
  16. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361:1935–1944
  17. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451–458
  18. Komiya N, Gu Y, Kamiya H, Yahata Y, Matsui T, Yasui Y, et al. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009. Euro Surveill 2009;14:pii: 19272.
  19. Koliou M, Soteriades ES, Toumasi MM, Demosthenous A, Hadjidemetriou A. Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June–August 2009. Euro Surveill 2009;14:pii: 19312.
  20. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep 2009;58:1071–4.
  21. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749–52.
  22. Liang M, Lye DC, Chen MI, Chow A, Krishnan P, Seow E, et al. New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases. Singapore Med J. 2009;50:581–583
  23. Centers for Disease Control and Prevention (CDC). Neurologic complications associated with novel influenza A (H1N1) virus infection in children—Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009;58:773–8.
  24. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women—United States, April–May 2009. MMWR Morb Mortal Wkly Rep 2009;58:497–500.
  25. Bin C, Xingwang L, Yuelong S, Nan J, Shijun C, Xiayuan X, et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis. 2009;15:1418–1422
  26. Wiebe C, Reslerova M, Komenda P, Bueti J, Rigatto C, Sood MM. Atypical clinical presentation of H1N1 influenza in a dialysis patient. Lancet. 2009;374:1300
  27. Cheng VC, Lau YK, Lee KL, Yiu KH, Chan KH, Ho PL, et al. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus. J Infect. 2009;59:366–370
  28. Dean A, Sullivan K, Soe M. Open source epidemiologic statistics for public health, version 2.2.1. Updated 2008/04/06. http://www.OpenEpi.com [accessed 18 September 2008].
  29. World Health Organization. Pandemic (H1N1) 2009—update 74. Geneva, Switzerland: WHO; 2009. http://www.who.int/csr/don/2009_11_13/en/index.html [accessed 22 January 2010].
  30. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dis. 2009;15:2004–2007
  31. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009;14:pii: 19288.
  32. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, et al. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9:537–545
  33. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ. 2009;339:b5106
  34. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176:463–468

PII: S0924-8579(10)00039-7

doi: 10.1016/j.ijantimicag.2010.01.006

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 421-430 , May 2010